Reimbursement for NHS Mounjaro dispensing confirmed for September 2025 Community Pharmacy England has reached an agreement with the Department of Health and Social Care to ensure that pharmacy owners are not dispensing at a loss.…
Pharmacists found to significantly reduce hospitalisations from heart failure Researchers found that hospital-affiliated or clinic-based pharmacists could help prevent unplanned hospitalisations in high-risk patients with heart failure.…
First home-based digital technologies approved for cardiac rehabilitation The National Institute for Health and Care Excellence said digital technologies could offset the low uptake of traditional cardiac rehabilitation programmes.…
Chronic heart failure deaths could fall by 3,000 per year following updated guidance, says NICE The National Institute for Health and Care Excellence said that drugs are being introduced earlier in patient treatment for chronic heart failure, which has been reflected in its draft guidance.…
Case-based learning: pharmacy involvement in congenital heart disease A comprehensive overview of the journey of a patient with congenital heart disease, from foetal to paediatric care, including perspectives from the parents and the medical team.…
Congenital heart disease: an overview An overview of the causes, diagnosis and treatments for congenital heart disease.…
Earlier treatment with combination of drugs could prevent 5,000 heart attacks per decade, study results suggest Researchers found that patients who received a combination treatment of statins and ezetimibe within 12 weeks of a heart attack and lowered their cholesterol to target-level early were less at risk of heart attacks, strokes and deaths.…
NHS increases funding for inclisiran although uptake remains ‘slower than expected’ In a letter sent to colleagues, NHS England said it had increased the reimbursement fee for inclisiran from £50 to £60.…
Two-thirds of cholesterol point-of-care tests fail to meet standards, researchers warn Authors of a literature review found that only two out of six point-of-care tests “mostly met” necessary standards for use in the NHS Health Check programme.…
Inclisiran prescribed to 7% of expected target population in three years, NHS data reveal Exclusive: The Royal College of General Practitioners and the British Medical Association maintain that caution should be taken when prescribing inclisiran since long-term trial data on the drug will not be available until 2026.…
